Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year

IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

See all formats and pricing
More options …
Volume 39, Issue 4 (Apr 2001)


Aggregation-Dependent Interaction of the Alzheimers β-Amyloid and Microglia

Frank Muehlhauser / Ulrike Liebl / Sandra Kuehl / Silke Walter / Thomas Bertsch / Klaus Faßbender
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.2001.048


Chronic glial activation possibly plays a role in chronic neurodegeneration in Alzheimer's disease (AD). It has been shown that amyloid peptide is capable of activating microglial cells in vitro. The aim of this study was to further characterize the structural preconditions for amyloid peptide in order to activate glial cells and to investigate whether this peptide is also able to induce glial activation in the living brain.

We observed that amyloid peptide induced strong cellular activation in primary microglial cell culture as detected by the release of stable metabolites of nitric oxide (NO), when the peptide was fibrillar. For this activation, co-stimulation with interferon-γ was a precondition. Using microdialysis of the living brain in a rat we observed pronounced NO generation when fibrillar amyloid peptide was stereotaxically injected. Non-fibrillar amyloid peptide did not induce such a glial reaction. No administration of interferon-γ or any other co-stimulatory factor was necessary in vivo.

Thus, we show that fibrillar, but not non-fibrillar amyloid peptide induced glial activation also in vivo. In the case of the living brain, the presence of deposits of fibrillar amyloid peptide could maintain a chronic microglial activation, ultimately leading to the progressive neurodegeneration associated with Alzheimer's disease.

About the article

Published Online: 2005-06-01

Published in Print: 2001-04-25

Citation Information: Clinical Chemistry and Laboratory Medicine, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.2001.048.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

Izumi Maezawa, Pavel I. Zimin, Heike Wulff, and Lee-Way Jin
Journal of Biological Chemistry, 2011, Volume 286, Number 5, Page 3693
Minsook Ye, Hwan-Suck Chung, Chanju Lee, Moon Sik Yoon, A. Ram Yu, Jin Su Kim, Deok-Sang Hwang, Insop Shim, and Hyunsu Bae
Journal of Neuroinflammation, 2016, Volume 13, Number 1
Zhiyou Cai, M. Delwar Hussain, and Liang-Jun Yan
International Journal of Neuroscience, 2014, Volume 124, Number 5, Page 307
Alexandra Stolzing, Rebecca Widmer, Tobias Jung, Peter Voss, and Tilman Grune
Free Radical Biology and Medicine, 2006, Volume 40, Number 12, Page 2126
A. Stephan and A. G. Phillips
Genes, Brain and Behavior, 2005, Volume 4, Number 3, Page 157
Alexandra Stolzing and Tilman Grune
Journal of Neuroscience Research, 2003, Volume 71, Number 2, Page 264

Comments (0)

Please log in or register to comment.
Log in